• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Sep 8
8:00 am - 9:00 am EDT

Member Forum: Health Literacy & Understanding ALS/MND

Sep 8
6:00 pm - 7:00 pm EDT

Member Forum: Health Literacy & Understanding ALS/MND

Oct 13
8:00 am - 9:00 am EDT

Member Forum: Technology Solutions for PALS

Oct 13
6:00 pm - 7:00 pm EDT

Member Forum: Technology Solutions for PALS

Oct 15
9:00 am - 10:00 am EDT

Webinar: The Use of AI in Voice and Communication

View Calendar

  • Fayette Underwood, USA

    Fayette Underwood, USA

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Alex, Argentina

    Alex, Argentina

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Zabun Nassar, England

    Zabun Nassar, England

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Daniel Hare, USA

    Daniel Hare, USA

  • Jon Newsome, USA

    Jon Newsome, USA

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Phil Rossall, UK

    Phil Rossall, UK

  • Timmy, Belgium

    Timmy, Belgium

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Ali Var, Turkey

    Ali Var, Turkey

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Sally Pauls, USA

    Sally Pauls, USA

  • John Sweeney, USA

    John Sweeney, USA

  • Animesh Kumar, India

    Animesh Kumar, India

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Denis Blais, Canada

    Denis Blais, Canada

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Willi Klein, UK

    Willi Klein, UK

  • David Solomon, UK

    David Solomon, UK

  • Dorette Lüdi, Switzerland

    Dorette Lüdi, Switzerland

  • Jay Epstein, USA

    Jay Epstein, USA

  • Len Johnrose, England

    Len Johnrose, England

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Daniela Maria Daverio, Argentina

    Daniela Maria Daverio, Argentina

  • Bob Simonds, USA

    Bob Simonds, USA

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Michael Lee, Australia

    Michael Lee, Australia

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login